Browse EX-10 agreements

** **

Form of Debt Forgiveness and Release Agreement

** **

Dated as of August 26, 2026

This Debt Forgiveness and Release Agreement (this “Agreement”), dated as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware corporation (the “Company”) and ____________ (“Counterparty”). Each of the Company and Counterparty may be referred to herein individually as a “Party” and collectively as the “Parties”.

RECITALS

WHEREAS, Counterparty is engaged by the Company as an employee, officer, consultant or in another position, and the Company currently owes the Counterparty the sum of $________ (the “Cash Debt”);

WHEREAS, Counterparty now desires to terminate and forgive The Cash Debt $_________ (the “Debt”), and provide the release and other agreements as set forth herein;

…

AM PM Group Limited

**Ritter House, Wickhams Cay II, PO Box 3170, Road Town, Tortola VG1110, British Virgin Islands

**

Date: July 6, 2026

Re: Director Offer Letter for Sun Wai Kenneth Liu

** **

Dear Sun Wai Kenneth Liu:

AM PM Group Limited, a British Virgin Islands company with limited liability (the “Company” or “we”), is pleased to offer you a position as an Independent Director of the Company. We believe your background and experience will be a significant asset to the Company and we look forward to your participation as an Independent Director in the Company. Should you choose to accept this position as an Independent Director, this offer letter shall constitute an employment agreement between you and the Company (the “Agreement”) and contains all the terms and conditions relating to the services you agree to provide to the Company. Your appointment shall begin upon Nasdaq’s approval of Company’s listing.

…

CROWDSTRIKE HOLDINGS, INC.

OUTSIDE DIRECTOR COMPENSATION POLICY

CrowdStrike Holdings, Inc. (the “Company”) believes that the granting of equity and cash compensation to its members of the Board of Directors (the “Board,” and members of the Board, “Directors”) represents a powerful tool to attract, retain and reward Directors who are not employees of the Company (“Outside Directors”).  This Outside Director Compensation Policy (the “Policy”) is intended to formalize the Company’s policy regarding cash compensation and grants of equity to its Outside Directors.   Unless otherwise defined herein, capitalized terms used in this Policy will have the meaning given such term in the CrowdStrike Holdings, Inc. 2019 Equity Incentive Plan (the “Plan”).  Outside Directors will be solely responsible for any tax obligations they incur as a result of the equity and cash payments received under this Policy.

1.    CASH COMPENSATION

…

Exhibit 10(a)

GRANT AGREEMENT

Director Name:         

Grant Date:        Grant Number:        Award Amount:        Award Type:            Restricted Stock UnitsPlan:            Fifth Amended and Restated HP Inc. 2004 Stock Incentive PlanVesting Schedule:        100% on the Grant Date

Restricted Stock Units

…

Okta, Inc.

Amended and Restated

Outside Director Compensation Policy

The purpose of this Outside Director Compensation Policy (this “Policy”) of Okta, Inc., a Delaware corporation (the “Company”), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors, who are not employees or officers of the Company or its subsidiaries (“Outside Directors”), to serve on the Company’s Board of Directors (the “Board”). In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:

1.Cash Retainers

Effective as of March 19, 2026, the cash retainers for the Board, the Lead Independent Director, and the members and Chairpersons of any standing committee of the Board (as may be constituted from time to time) are revised as set forth below:

(a)Annual Board Membership Retainer. $35,000 for general availability and participation in meetings and conference calls of the Board.

…

** **

AMENDMENT

TO THE

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Amendment No. 7 (this “Amendment”), dated as of August 20, 2026, to the Investment Management Trust Agreement (as defined below) is made by and between Technology & Telecommunication Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). All terms used but not defined herein shall have the meanings assigned to them in the Trust Agreement.

WHEREAS, the Company and the Trustee entered into an Investment Management Trust Agreement dated as of January 14, 2022 (as amended on by Amendment No. 1, Amendment No.2, Amendment No.3, Amendment No. 4 Amendment No. 5, and Amendment No. 6 thereto, the “Trust Agreement”);

WHEREAS, Section 1(i) of the Trust Agreement sets forth the terms that govern the liquidation of the Trust Account under the circumstances described therein;

…

AUTONOMIX MEDICAL, INC.

August 24, 2026

Holder of Common Stock Purchase Warrants

Re:         Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Autonomix Medical, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise all of the Series D-1 warrants and Series D-2 warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued to you on July 15, 2026 (the “Existing Warrants”), as set forth on the signature page hereto and currently held by you (the “Holder”). The issuance of the shares of Common Stock underlying the Existing Warrants (the “Warrant Shares”) has been registered for resale pursuant to the registration statement on Form S-3 (File No. 333-297760) (the “Registration Statement”). The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to this letter agreement, will be effective for the resale of the Warrant Shares.** **Capitalized terms not otherwise defined herein shall have the meanings set forth in the New Warran

…

IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE “CONFIDENTIAL INFORMATION”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****].

REAL ESTATE PURCHASE AND SALE AGREEMENT

THIS REAL ESTATE PURCHASE AND SALE AGREEMENT (the “Agreement”) is made and entered into as of the 16th day of August, 2026 (the “Effective Date”) by and between Unifi Manufacturing, Inc., a North Carolina corporation (the “Seller”), and ENOVUM DATA CENTERS CORP., a Canadian corporation and its permitted assigns (the “Buyer”) (Buyer and Seller are referred to herein individually as a “Party” and, together, the “Parties”).

STATEMENT OF PURPOSE

** **

A. Seller is the owner of that certain real property situated in Yadkin County, North Carolina and being more particularly described as follows:

…

BIOMERICA, INC.

SECURITIES PURCHASE AGREEMENT

This SECURITIES Purchase Agreement (this “Agreement”) is dated as of August 20, 2026, by and between Biomerica, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, “Purchaser” and collectively the “Purchasers”).

Whereas, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

Now, Therefore, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

Article I

DEFINITIONS

…